Indications and uses
for the temporary relief of minor aches and pains due to: Headache Muscular aches Backache Minor pain of arthritis The common cold Toothache Premenstrual and menstrual cramps Temporarily reduces fever.
Extra Strength Mapap
- Manufacturer
- H.J. Harkins Company, Inc.
- Effective date
- 2012-01-31
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:30:56
Label at a glance#
ProductExtra Strength Mapap
Active ingredientACETAMINOPHEN
Label structure9 sections
Dosage and administration
Do not take more than directed Adults and children 12 years and over: take 2 caplets every 4 to 6 hours while symptoms last do not take more than 8 caplets in 24 hours Do not take for more than 10 days unless directed by a doctor Children under 12 years: do not use adult Extra Strength product in children under 12 years of age; this will provide more than the recommended dose (overdose) of acetaminophen and may ca...
Contacts and useful links#
Label contents#
Full prescribing information#
Active Ingredient (in each caplet)
Acetaminophen 500 mg
Purpose
Pain Reliever/Fever Reducer
Uses
for the temporary relief of minor aches and pains due to:
- Headache
- Muscular aches
- Backache
- Minor pain of arthritis
- The common cold
- Toothache
- Premenstrual and menstrual cramps
Warnings
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
- more than 8 caplets in 24 hours,which is the maximum daily amount
- with other drugs containing acetaminophen
- 3 or more alcoholic drinks every day while using this product
Do not use
- with any other drug containing acetaminophen (prescription or non prescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
- if you are allergic to acetaminophen or any of the inactive ingredients in this product
Ask a doctor before use if you have
liver disease
Ask a doctor or pharmacist before use if you are
taking the blood thinning drug warfarin
Stop use and ask a doctor if
- Pain gets worse or lasts more than 10 days
- Fever gets worse or lasts more than 3 days
- New symptoms occur
- Redness or swelling is present
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children
OVERDOSAGE SECTION
Overdose warning: Taking more than the recommended dose (overdose) may cause liver damage. In the case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Directions
Do not take more than directed
Adults and children 12 years and over:
- take 2 caplets every 4 to 6 hours while symptoms last
- do not take more than 8 caplets in 24 hours
- Do not take for more than 10 days unless directed by a doctor
Children under 12 years: do not use adult Extra Strength product in children under 12 years of age; this will provide more than the recommended dose (overdose) of acetaminophen and may cause liver damage.
Other information
- Do not use if imprinted safety seal under cap is broken or missing.
- store at room temperature
Inactive ingredients
Hypromellose, Polyethylene Glycol, Povidone, Pregelatinized Starch, Sodium Starch Glycolate, Stearic Acid
Questions?
Adverse Drug Events call (800) 616-2471
Repacked by:
H.J. Harkins Company, Inc.
513 Sandydale Drive
Nipomo, CA 93444
Principal Display Panel of Extra Strength Mapap 500 mg Caplets
NDC 0904-1983-60
MAJOR®
Extra Strength
Mapap
ASPIRIN FREE
ACETAMINOPHEN
STRONG PAIN &
FEVER RELIEF
CAPLETS
Compare to active ingredient in Extra Strength Tylenol® Caplets*
*This product is not manufactured or distributed by McNeil Consumer Products Co., owner of the registered trademark Tylenol®.
100 Caplets
500 mg. Each
NDC 0904-1983-24
MAJOR®
EXTRA STRENGTH
Mapap
ASPIRIN FREE
ACETAMINOPHEN
STRONG PAIN & FEVER RELIEF
CAPLETS
Compare to the active ingredients in Extra Strength Tylenol® Caplets*
See New Warning Information
24 Caplets
500 mg. Each
Repacked by:
H.J. Harkins Company, Inc.
Nipomo, CA 93444
*This product is not manufactured or distributed by McNeil Consumer Products Co., owner of registered trademark Tylenol®
Extra Strength Mapap 500 mg caplets 24 ct boxed product label
MAJOR®
| See New Warnings Information |
Mapap
ASPIRIN FREE
ACETAMINOPHEN
STRONG PAIN &
FEVER RELIEF
CAPLETS
Compare to active ingredient in Extra Strength Tylenol® Caplets*
*This product is not manufactured or distributed by McNeil Consumer Products Co., owner of the registered trademark Tylenol®.
100 Caplets
500 mg. Each
NDC 0904-1983-24
MAJOR®
EXTRA STRENGTH
Mapap
| See New Warnings Information |
ACETAMINOPHEN
STRONG PAIN & FEVER RELIEF
CAPLETS
Compare to the active ingredients in Extra Strength Tylenol® Caplets*
See New Warning Information
24 Caplets
500 mg. Each
Repacked by:
H.J. Harkins Company, Inc.
Nipomo, CA 93444
*This product is not manufactured or distributed by McNeil Consumer Products Co., owner of registered trademark Tylenol®
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | 1 |
| 209443 | MAPAP Extra Strength 500 MG Oral Tablet | PSN | 1 |
| 209443 | acetaminophen 500 MG Oral Tablet [Mapap] | SBD | 1 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | 1 |
| 198440 | APAP 500 MG Oral Tablet | SY | 1 |
| 209443 | APAP 500 MG Oral Tablet [Mapap] | SY | 1 |
| 209443 | Extra Strength Mapap 500 MG Oral Tablet | SY | 1 |
| 209443 | Mapap 500 MG Oral Tablet | SY | 1 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52959-338-00 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ced8-f6ea-e053-dbdaa90aa703 | Drug Facts |
| 52959-338-10 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ced8-f6ea-e053-dbdaa90aa703 | Drug Facts |
| 52959-338-12 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ced8-f6ea-e053-dbdaa90aa703 | Drug Facts |
| 52959-338-20 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ced8-f6ea-e053-dbdaa90aa703 | Drug Facts |
| 52959-338-24 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ced8-f6ea-e053-dbdaa90aa703 | Drug Facts |
| 52959-338-30 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ced8-f6ea-e053-dbdaa90aa703 | Drug Facts |
| 52959-338-40 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ced8-f6ea-e053-dbdaa90aa703 | Drug Facts |
| 52959-338-50 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ced8-f6ea-e053-dbdaa90aa703 | Drug Facts |
| 52959-338-60 | 2019-11-13 | C162847 | 48780-1 | 97449f38-ced8-f6ea-e053-dbdaa90aa703 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-338-00 | Extra Strength Mapap | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 1 | |
| 52959-338-10 | Extra Strength Mapap | 10 in 1 BOTTLE | TABLET, FILM COATED | 10 | 1 | |
| 52959-338-12 | Extra Strength Mapap | 12 in 1 BOTTLE | TABLET, FILM COATED | 12 | 1 | |
| 52959-338-20 | Extra Strength Mapap | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 1 | |
| 52959-338-24 | Extra Strength Mapap | 24 in 1 BOTTLE | TABLET, FILM COATED | 24 | 1 | |
| 52959-338-30 | Extra Strength Mapap | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 | |
| 52959-338-40 | Extra Strength Mapap | 40 in 1 BOTTLE | TABLET, FILM COATED | 40 | 1 | |
| 52959-338-50 | Extra Strength Mapap | 50 in 1 BOTTLE | TABLET, FILM COATED | 50 | 1 | |
| 52959-338-60 | Extra Strength Mapap | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACETAMINOPHEN | ACTIVE INGREDIENT | 362O9ITL9D | 1 | |
| ACETAMINOPHEN | ACTIVE MOIETY | 362O9ITL9D | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| POLYETHYLENE GLYCOL | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 |
Products#
Every source-derived product name is available through these pages.
- Extra Strength Mapap
- ACETAMINOPHEN
- HYPROMELLOSES
- POLYETHYLENE GLYCOL
- POVIDONE
- STARCH, CORN
- SODIUM STARCH GLYCOLATE TYPE A POTATO
- STEARIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 52959-338 | 52959-338-00, 52959-338-10, 52959-338-12, 52959-338-20, 52959-338-24, 52959-338-30, 52959-338-40, 52959-338-50, 52959-338-60 |
| 0904-1983 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| POLYETHYLENE GLYCOL | 3WJQ0SDW1A | IACT |
| POVIDONE | FZ989GH94E | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| POVIDONE | POVIDONE | FZ989GH94E | CAPSULE, DELAYED RELEASE / ORAL | NA | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | INJECTION / INTRAMUSCULAR | 0.2 %w/v | ||
| POVIDONE | POVIDONE | FZ989GH94E | SYSTEM / TOPICAL | 41 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | PASTILLE / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, ORALLY DISINTEGRATING / ORAL | 41 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | POWDER, FOR SUSPENSION / ORAL | 34 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TROCHE / ORAL | 30 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | SUSPENSION / AURICULAR (OTIC) | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, DELAYED RELEASE / ORAL | 216 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, ORALLY DISINTEGRATING / ORAL | 15.03 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYSTEM / TOPICAL | 54 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | 79 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | DROPS / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FOR SUSPENSION / ORAL | 2 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 350 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| POVIDONE | POVIDONE | FZ989GH94E | SUSPENSION / OPHTHALMIC | 1.8 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | 0.1 %w/w | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | JELLY / TOPICAL | NA | ||
| POVIDONE | POVIDONE | FZ989GH94E | SOLUTION / ORAL | 3000 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, CHEWABLE / ORAL | 48 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, DELAYED RELEASE / ORAL | 713 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, EXTENDED RELEASE / ORAL | 184 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | 45 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | CAPSULE, EXTENDED RELEASE / ORAL | 56 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 17 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | INSERT / VAGINAL | 54.21 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | 105 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 32 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE / ORAL | 5785 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | CAPSULE / ORAL | 300 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 976d0a7b-0607-453e-82df-3eb3fa19d1ce | 0eb4c569-08bd-4a37-a0bb-0aadb7294192 | 2012-01-31 | Warnings | 976d0a7b-0607-453e-82df-3eb3fa19d1ce 0eb4c569-08bd-4a37-a0bb-0aadb7294192 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.